Publications

Members only publications are marked with a lock icon:
Filter By
JAMDA
March 1, 2022
Polypharmacy in long-term care (LTC) facilities is an ongoing concern. To address this issue, the Drive to Deprescribe (D2D) initiative targets reduction of antihyperglycemic agents to improve quality of life and reduce risk of hypoglycemia.
JAMDA
March 1, 2022
With over 1200 nursing homes (NH) in Texas, there is a need for support and education of NH teams. The Project ECHO (Extension for Community Healthcare Outcomes) platform provides a model for creating interactive and interdisciplinary learning...
JAMDA
March 1, 2022
Xanthogranulomatous Pyelonephritis (XGP) is a rare cause of recurrent UTIs in the nursing home setting.
JAMDA
March 1, 2022
This case emphasizes the importance of eliciting a patient’s care goals. These conversations, although ideally done early on in a disease trajectory, can be appropriate and necessary to have in the hospital especially prior to discharge to the post-...
JAMDA
March 1, 2022
Voluntary stopping of eating and drinking (VSED) is a last resort to end one’s life when the suffering is unbearable. Since the VSED requires strong will to complete, its occurrence is rare. VSED in a long-term care setting is not well reported.
JAMDA
March 1, 2022
Temporomandibular joint disorder (TMD) is estimated to impact 3-5% of American adults over age 65. Severe symptoms refractory to traditional pharmacologic care can pose a large burden on older adults.
JAMDA
March 1, 2022
Calciphylaxis is an infrequent, life-threatening syndrome of vascular calcification characterized by occlusion of microvessels in the subcutaneous adipose tissue and dermis that results in skin necrosis, commonly encountered in patients with end-...
JAMDA
March 1, 2022
Medications are associated with development of adverse drug events (ADEs), some more than others, due to alteration in pharmacokinetics and dynamics with age. Phenytoin efficacy and toxicity relate to drug levels, interaction with cytochrome P450,...
JAMDA
March 1, 2022
The number of patients living with end-stage heart failure is steadily growing. Although originally intended to serve solely as a bridge to more definitive surgical therapies, there is an increasing number of patients receiving inotropic therapy (...
JAMDA
March 1, 2022
Dopamine, a neurotransmitter for motor function, is implicated in dyskinetic illness. Movement disorders are significant adverse drug effects (ADEs) of several psychotropic drugs with anti-dopamine action. Buspirone, an azapirone, is a partial...